
Expert preclinical testing
for oligonucleotides
Move your oligo compound forward through discovery, IND and NDA submission with WuXi AppTec. We provide fully integrated programs that address the bioanalytical, DMPK, and toxicology testing needs of your oligonucleotide candidate—helping you meet the strict demands of your development timeline.
Tell us more about your specific needs by filling out the form on the right and one of our experts will be in touch.
A fully integrated program for oligonucleotides
We combine world-class, cross-functional drug development testing, global regulatory expertise, and years of experience working with oligonucleotides to shepherd you through the development life cycle.
DPMK
Bioanalysis
Toxicology
Pharmacology
CMC
Regulatory Affairs
Your end-to-end preclinical testing partner
With capabilities in DMPK/ADME, bioanalytical, safety assessment, pharmacology, Chemistry, Manufacturing and Controls (CMC) and analytical services all under one roof, WuXi AppTec is a global expert in preclinical development testing and can support the full scope of your development program, from discovery to IND-enabling studies to NDA submission.